{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:04:08Z","timestamp":1780628648326,"version":"3.54.1"},"reference-count":31,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Statutory Activities by the Minister of Science and Higher Education","award":["SUBZ.C120.23.042"],"award-info":[{"award-number":["SUBZ.C120.23.042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Uncontrolled acromegaly causes increased morbidity and mortality. The analysis of acromegaly comorbidities and complications is important when establishing a standard of care for the entire population of acromegaly patients. The aim of this study was to determine the frequency of comorbidities and complications of acromegaly and their dependence on the activity of the disease. A retrospective analysis of medical records from 124 patients with acromegaly was carried out, including 39 who were cured, 73 treated with somatostatin analogs and 12 newly diagnosed patients. The incidence of comorbidities and complications was very high, and those most frequently observed were arterial hypertension, multinodular goiter, lipid disorders, hypopituitarism and degenerative changes. At least one complication of acromegaly was observed in 92% of patients undergoing successful neurosurgery and in all pharmacologically treated patients. By contrast, two or more complications were observed in 77% of cured patients and in pharmacologically controlled and uncontrolled patients, 82% and 91%, respectively. Conclusions: Acromegaly is associated with a high prevalence of complications. Active acromegaly is associated with a higher incidence of complications than in treated groups. Untreated patients have more complications than treated patients. Successfully cured patients have significantly fewer complications than pharmacologically controlled patients and patients with active acromegaly.<\/jats:p>","DOI":"10.3390\/jcm12196309","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:28:08Z","timestamp":1696220888000},"page":"6309","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Relationship between the Burden of Acromegaly, Associated Comorbidities, Complications and Disease Status"],"prefix":"10.3390","volume":"12","author":[{"given":"Micha\u0142","family":"Elbaum","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 4, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ka\u0142u\u017cny","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 4, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Jawiarczyk-Przyby\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 4, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Wojtczak","sequence":"additional","affiliation":[{"name":"Department of General, Minimally Invasive and Endocrine Surgery, Wroclaw Medical University, Borowska Str. 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Zieli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Military Institute of Medicine\u2014National Research Institute, 128 Szaser\u00f3w Str., 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-6596","authenticated-orcid":false,"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 4, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.a2018.0093","article-title":"Diagnostics and Treatment of Acromegaly\u2014Updated Recommendations of the Polish Society of Endocrinology","volume":"70","author":"Bolanowski","year":"2019","journal-title":"Endokrynol. Pol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in Acromegaly Decreased in the Last Decade: A Systematic Review and Meta-Analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1159\/000505332","article-title":"Natural History of Acromegaly: Incidences, Re-Operations, Cancers, and Mortality Rates in a National Cohort","volume":"110","author":"Wu","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of Acromegaly","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","article-title":"Features at Diagnosis of 324 Patients with Acromegaly Did Not Change from 1981 to 2006: Acromegaly Remains under-Recognized and under-Diagnosed","volume":"72","author":"Reid","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1015713732717","article-title":"Acromegaly and Cancer Risk: A Cohort Study in Sweden and Denmark","volume":"13","author":"Baris","year":"2002","journal-title":"Cancer Causes Control."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1210\/jc.2018-00325","article-title":"Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly","volume":"103","author":"Vargas","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful Mortality Reduction and Control of Comorbidities in Patients with Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and Incidence of Pituitary Adenomas: A Population Based Study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Li\u00e8ge, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly Incidence, Prevalence, Complications and Long-Term Prognosis: A Nationwide Cohort Study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11102-015-0655-4","article-title":"The Incidence and Prevalence of Acromegaly, a Nationwide Study from 1955 through 2013","volume":"18","author":"Hoskuldsdottir","year":"2015","journal-title":"Pituitary"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, Clinical Characteristics, Outcome, Morbidity and Mortality in Acromegaly Based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11102-010-0281-0","article-title":"Frequency of Acromegaly in Adults with Diabetes or Glucose Intolerance and Estimated Prevalence in the General Population","volume":"14","author":"Rosario","year":"2011","journal-title":"Pituitary"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12020-018-1538-z","article-title":"IGF-1-Based Screening Reveals a Low Prevalence of Acromegaly in Patients with Obstructive Sleep Apnea","volume":"60","author":"Heinrich","year":"2018","journal-title":"Endocrine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","first-page":"A1","article-title":"2016 Guidelines on the Management of Diabetic Patients. A Position of Diabetes Poland","volume":"5","author":"Araszkiewicz","year":"2016","journal-title":"Diabetol. Klin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1210\/clinem\/dgz096","article-title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","volume":"105","author":"Giustina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-16-0623","article-title":"Comorbidities, Treatment Patterns and Cost-of-Illness of Acromegaly in Sweden: A Register-Linkage Population-Based Study","volume":"176","author":"Granfeldt","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.12669\/pjms.37.7.4277","article-title":"Prevalence of Comorbidities among Patients with Acromegaly","volume":"37","author":"Khan","year":"2021","journal-title":"Pak. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1815","DOI":"10.1210\/clinem\/dgz317","article-title":"Risk for Acromegaly-Related Comorbidities by Sex in Korean Acromegaly","volume":"105","author":"Park","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","first-page":"448","article-title":"High Prevalence of Acromegaly in Different Industrial Areas: A Population-Based Study from Haifa and Western Galilee District in Northern Israel","volume":"24","author":"Zaina","year":"2022","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"642131","DOI":"10.3389\/fendo.2021.642131","article-title":"Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center","volume":"12","author":"Rolla","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5603\/EP.a2020.0050","article-title":"Therapeutic Effect of Presurgical Treatment with Longacting Octreotide (Sandostatin\u00ae LAR\u00ae) in Patients with Acromegaly","volume":"71","author":"Bolanowski","year":"2020","journal-title":"Endokrynol. Pol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fpubh.2020.00147","article-title":"New Epidemiological, Clinical and Economic Data for Patients with Acromegaly in Bulgaria","volume":"8","author":"Kamusheva","year":"2020","journal-title":"Front. Public. Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","article-title":"Prevalence of Comorbidities and Concomitant Medication Use in Acromegaly: Analysis of Real-World Data from the United States","volume":"25","author":"Fleseriu","year":"2022","journal-title":"Pituitary"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40801-015-0039-0","article-title":"Treatment Patterns and Economic Burden in Patients Treated for Acromegaly in the USA","volume":"2","author":"Chuang","year":"2015","journal-title":"Drugs Real World Outcomes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11102-015-0654-5","article-title":"Incremental Healthcare Resource Utilization and Costs in US Patients with Cushing\u2019s Disease Compared with Diabetes Mellitus and Population Controls","volume":"18","author":"Broder","year":"2015","journal-title":"Pituitary"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.eprac.2021.04.412","article-title":"Health Benefit Costs and Absenteeism Among Employed Patients with Acromegaly","volume":"27","author":"Yuen","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-020-01102-7","article-title":"Biliary Adverse Events in Acromegaly during Somatostatin Receptor Ligands: Predictors of Onset and Response to Ursodeoxycholic Acid Treatment","volume":"24","author":"Prencipe","year":"2021","journal-title":"Pituitary"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6309\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:02:48Z","timestamp":1760130168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":31,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["jcm12196309"],"URL":"https:\/\/doi.org\/10.3390\/jcm12196309","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]}}}